Xiangquan Kong Selected Research

Xiangquan Kong Research Topics

Disease

6	Inflammation (Inflammations) 03/2023 - 08/2012
5	Neoplasms (Cancer) 04/2023 - 10/2013
3	Atherosclerosis 03/2023 - 01/2022
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2017
2	Nasopharyngeal Carcinoma 12/2021 - 01/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2023
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2023
1	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pneumothorax 01/2021
1	Ischemic Stroke 05/2019
1	Hemorrhage 05/2019
1	Atrial Fibrillation 05/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2019
1	Dermatofibrosarcoma 01/2019
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Glioma (Gliomas) 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 02/2016
1	Poisoning 04/2014
1	Body Weight (Weight, Body) 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Astrocytoma (Pilocytic Astrocytoma) 10/2013
1	Renal Insufficiency (Renal Failure) 10/2013
1	Congenital Heart Defects (Congenital Heart Defect) 10/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2012
1	Parkinson Disease (Parkinson's Disease) 08/2012

Drug/Important Bio-Agent (IBA)

2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2022
2	Type 1 Angiotensin ReceptorIBA 02/2018 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 10/2013
1	Phosphotransferases (Kinase)IBA 04/2023
1	Immune Checkpoint InhibitorsIBA 04/2023
1	QuercetinIBA 03/2023
1	Eukaryotic Initiation Factor-3IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2022
1	LipidsIBA 01/2022
1	IntegrinsIBA 01/2022
1	GATA2 Transcription FactorIBA 01/2022
1	GlycosaminoglycansIBA 08/2019
1	Hyaluronic Acid (Hyaluronan)IBA 08/2019
1	AnticoagulantsIBA 05/2019
1	N(4)-oleylcytosine arabinosideIBA 05/2019
1	Vitamin K FDA Link 05/2019
1	Clopidogrel (Plavix)FDA Link 05/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2019
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2019
1	Pyrrolizidine AlkaloidsIBA 01/2019
1	alpha-hydroxyglutarateIBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 11/2017
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 11/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2016
1	Pyruvic Acid (Pyruvate)IBA 02/2016
1	EdaravoneIBA 04/2014
1	AntioxidantsIBA 04/2014
1	ParaquatIBA 04/2014
1	ORALIT (ORS)IBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Insulin Receptor Substrate ProteinsIBA 01/2014
1	Insulin ReceptorIBA 01/2014
1	AlbuminsIBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014
1	Oncogene Proteins (Oncogene Protein)IBA 10/2013
1	AntigensIBA 10/2013
1	matrigelIBA 10/2013
1	Contrast MediaIBA 10/2013
1	BromidesIBA 10/2013
1	Glutamic Acid (Glutamate)FDA Link 08/2012
1	CalciumIBA 08/2012
1	PesticidesIBA 08/2012
1	Nerve Growth Factors (Neurotrophins)IBA 08/2012
1	SynucleinsIBA 08/2012
1	RotenoneIBA 08/2012

Therapy/Procedure

3	Radiotherapy 01/2019 - 01/2014
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2021 - 01/2014
2	Therapeutics 05/2019 - 04/2014
1	Intraperitoneal Injections 03/2023
1	Immunotherapy 01/2022
1	Punctures 01/2021
1	Percutaneous Coronary Intervention 05/2019
1	Drug Therapy (Chemotherapy) 01/2017